-
1
-
-
0026186292
-
Colon-specific drug delivery
-
Friend D.R. Colon-specific drug delivery. Adv. Drug Deliv. Rev. 7:1991;149-199
-
(1991)
Adv. Drug Deliv. Rev.
, vol.7
, pp. 149-199
-
-
Friend, D.R.1
-
2
-
-
0028058952
-
Glucocorticoid-dextran conjugates as potential prodrugs colon-specific delivery: Hydrolysis in rat gastrointestinal tract contents
-
McLeod A., Friend D.R., Tozer T.N. Glucocorticoid-dextran conjugates as potential prodrugs colon-specific delivery: hydrolysis in rat gastrointestinal tract contents. J. Pharm. Sci. 83:1994;1284-1288
-
(1994)
J. Pharm. Sci.
, vol.83
, pp. 1284-1288
-
-
McLeod, A.1
Friend, D.R.2
Tozer, T.N.3
-
3
-
-
0029020655
-
Colonic delivery of dexamethasone from a prodrug accelerates healing of colitis in rats without adrenal suppression
-
Fedorak R., Haeberlin B., Empey L.R., Cui N., Nolen H. III, Jewell L.D., Friend D.R. Colonic delivery of dexamethasone from a prodrug accelerates healing of colitis in rats without adrenal suppression. Gastroenterology. 108:1995;1688-1699
-
(1995)
Gastroenterology
, vol.108
, pp. 1688-1699
-
-
Fedorak, R.1
Haeberlin, B.2
Empey, L.R.3
Cui, N.4
Nolen III, H.5
Jewell, L.D.6
Friend, D.R.7
-
4
-
-
0028832474
-
Approaches and opportunities in colon-specific drug delivery
-
Rubinstein A. Approaches and opportunities in colon-specific drug delivery. Crit. Rev. Ther. Drug Carrier Syst. 12:1995;101-149
-
(1995)
Crit. Rev. Ther. Drug Carrier Syst.
, vol.12
, pp. 101-149
-
-
Rubinstein, A.1
-
7
-
-
0023781542
-
Gastrointestinal transit of small tablets in patients with ulcerative colitis
-
Hardy F.H., Davis S.S., Khosla R., Robertson C.S. Gastrointestinal transit of small tablets in patients with ulcerative colitis. Int. J. Pharmcol. 48:1988;79-82
-
(1988)
Int. J. Pharmcol.
, vol.48
, pp. 79-82
-
-
Hardy, F.H.1
Davis, S.S.2
Khosla, R.3
Robertson, C.S.4
-
8
-
-
0026499175
-
The transit rate of different-sized model dosage forms through the human colon and the effects of a lactulose-induced catharsis
-
Watts P.J., Barrow L., Steed K.P., Wilson C.G., Spiller R.C., Melia C.D., Davies M.C. The transit rate of different-sized model dosage forms through the human colon and the effects of a lactulose-induced catharsis. Int. J. Pharmcol. 87:1992;215-221
-
(1992)
Int. J. Pharmcol.
, vol.87
, pp. 215-221
-
-
Watts, P.J.1
Barrow, L.2
Steed, K.P.3
Wilson, C.G.4
Spiller, R.C.5
Melia, C.D.6
Davies, M.C.7
-
9
-
-
0032447773
-
Steroid-unresponsive acute attacks of inflammatory bowel disease: Immunomodulation by tacrolimus (FK506)
-
Fellermann K., Ludwig D., Stahl M., David-Walek T., Stange E.F. Steroid-unresponsive acute attacks of inflammatory bowel disease: immunomodulation by tacrolimus (FK506). Am. J. Gastroenterol. 93:1998;1860-1866
-
(1998)
Am. J. Gastroenterol.
, vol.93
, pp. 1860-1866
-
-
Fellermann, K.1
Ludwig, D.2
Stahl, M.3
David-Walek, T.4
Stange, E.F.5
-
10
-
-
0033845828
-
Tacrolimus in corticoid-resistant ulcerative colitis
-
Matsuhashi N., Nakajima A., Watanabe K., Komeno Y., Suzuki A., Ohnishi S., Omata M., Kondo K., Usui Y., Iwadare J.I., Watanabe T., Nagawa H., Muto T. Tacrolimus in corticoid-resistant ulcerative colitis. J. Gastroenterol. 35:2000;655-657
-
(2000)
J. Gastroenterol.
, vol.35
, pp. 655-657
-
-
Matsuhashi, N.1
Nakajima, A.2
Watanabe, K.3
Komeno, Y.4
Suzuki, A.5
Ohnishi, S.6
Omata, M.7
Kondo, K.8
Usui, Y.9
Iwadare, J.I.10
Watanabe, T.11
Nagawa, H.12
Muto, T.13
-
11
-
-
0035003791
-
A new 5-aminosalicylic acid multi-unit dosage form for the therapy of ulcerative colitis
-
Rudolph M., Klein S., Beckert T.E., Petereit H.U., Dressman J.B. A new 5-aminosalicylic acid multi-unit dosage form for the therapy of ulcerative colitis. Eur. J. Pharmcol. Biopharm. 51:2001;183-190
-
(2001)
Eur. J. Pharmcol. Biopharm.
, vol.51
, pp. 183-190
-
-
Rudolph, M.1
Klein, S.2
Beckert, T.E.3
Petereit, H.U.4
Dressman, J.B.5
-
12
-
-
0034879018
-
Application of Eudragit P-4135F for the delivery of ellagic acid to the rat lower small intestine
-
Jeong Y.I., Prasad Y.R., Ohno T., Yoshikawa Y., Shibata N., Kato S., Takeuchi K., Takada K. Application of Eudragit P-4135F for the delivery of ellagic acid to the rat lower small intestine. J. Pharm. Pharmacol. 53:2001;1079-1085
-
(2001)
J. Pharm. Pharmacol.
, vol.53
, pp. 1079-1085
-
-
Jeong, Y.I.1
Prasad, Y.R.2
Ohno, T.3
Yoshikawa, Y.4
Shibata, N.5
Kato, S.6
Takeuchi, K.7
Takada, K.8
-
13
-
-
0033399053
-
Characterization of norfloxacine release from tablet coated with a new pH-sensitive polymer, P-4135F
-
Hu Z., Shimokawa T., Ohno T., Kimura G., Mawatari S.S., Kamitsuna M., Yoshikawa Y., Masuda S., Takada K. Characterization of norfloxacine release from tablet coated with a new pH-sensitive polymer, P-4135F. J. Drug Target. 7:1999;223-232
-
(1999)
J. Drug Target.
, vol.7
, pp. 223-232
-
-
Hu, Z.1
Shimokawa, T.2
Ohno, T.3
Kimura, G.4
Mawatari, S.S.5
Kamitsuna, M.6
Yoshikawa, Y.7
Masuda, S.8
Takada, K.9
-
14
-
-
0026697912
-
Calcium alginate beads as core carriers of 5-aminosalicylic acid
-
Lin S.Y., Ayres J.W. Calcium alginate beads as core carriers of 5-aminosalicylic acid. Pharmcol. Res. 9:1992;1128-1131
-
(1992)
Pharmcol. Res.
, vol.9
, pp. 1128-1131
-
-
Lin, S.Y.1
Ayres, J.W.2
-
16
-
-
0344734115
-
Design of a new multiparticulate system for potential site-specific and controlled drug delivery to the colonic region
-
Rodriguez M., Vila-Jato J.L., Torres D. Design of a new multiparticulate system for potential site-specific and controlled drug delivery to the colonic region. J. Control. Release. 55:1998;67-77
-
(1998)
J. Control. Release
, vol.55
, pp. 67-77
-
-
Rodriguez, M.1
Vila-Jato, J.L.2
Torres, D.3
-
17
-
-
0029933674
-
Quantitative determination of tautomeric FK506 by reversed-phase liquid chromatography
-
Akashi T., Nefuji T., Yoshida M., Hosoda J. Quantitative determination of tautomeric FK506 by reversed-phase liquid chromatography. J. Pharmcol. Biomed. Anal. 14:1996;339-346
-
(1996)
J. Pharmcol. Biomed. Anal.
, vol.14
, pp. 339-346
-
-
Akashi, T.1
Nefuji, T.2
Yoshida, M.3
Hosoda, J.4
-
18
-
-
2942694958
-
-
Thermoplastic resin for enteric pharmaceutical coating, European patent EP 704,207, July 25, 2001.
-
K. Lehmann, W. Höss, Thermoplastic resin for enteric pharmaceutical coating, European patent EP 704, 207, July 25, 2001.
-
-
-
Lehmann, K.1
Höss, W.2
-
20
-
-
0032901219
-
Encapsulation of hydrophilic and lipophilic drugs in PLGA nanoparticles by the nanoprecipitation method
-
Barichello J.M., Morishita M., Takayama K., Nagai T. Encapsulation of hydrophilic and lipophilic drugs in PLGA nanoparticles by the nanoprecipitation method. Drug Dev. Ind. Pharmcol. 25:1999;471-476
-
(1999)
Drug Dev. Ind. Pharmcol.
, vol.25
, pp. 471-476
-
-
Barichello, J.M.1
Morishita, M.2
Takayama, K.3
Nagai, T.4
-
21
-
-
0035962390
-
Design of rolipram-loaded nanoparticles: Comparison of two preparation methods
-
Lamprecht A., Ubrich N., Yamamoto H., Schafer U., Takeuchi H., Lehr C.M., Maincent P., Kawashima Y. Design of rolipram-loaded nanoparticles: comparison of two preparation methods. J. Control. Release. 71:2001;297-306
-
(2001)
J. Control. Release
, vol.71
, pp. 297-306
-
-
Lamprecht, A.1
Ubrich, N.2
Yamamoto, H.3
Schafer, U.4
Takeuchi, H.5
Lehr, C.M.6
Maincent, P.7
Kawashima, Y.8
|